| Danville State Hospital | |
| 50 Kirkbride Drive, Danville, Pennsylvania 17821 | |
| (570) 271-4500 | |
| Not Available |
| Name | Danville State Hospital |
|---|---|
| Type | Psychiatric Hospital |
| Location | 50 Kirkbride Drive, Danville, Pennsylvania |
| Ownership | Government - State |
| Emergency Services | No |
| Medicare ID (CCN) | 394004 |
| NPI Number | 1457334336 |
| Organization Name | PENNSYLVANIA DEPARTMENT OF HUMAN SERVICES |
| Doing Business As | DANVILLE STATE HOSPITAL |
| Address | 50 Kirkbride Dr, Danville, PA 17821 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 570-271-4510 |
News Archive
Intact Vascular, Inc., a private medical device company committed to developing solutions for minimally invasive peripheral vascular procedures, today announced it received U.S. Food and Drug Administration approval for the Tack Endovascular System, a purpose-built dissection repair device implanted post-angioplasty in patients with peripheral arterial disease.
A study published in the Journal of Biological Chemistry is the first to describe a signaling pathway that affects communication - a process called quorum sensing - between Streptococcus bacteria cells.
Nabi Biopharmaceuticals today announced its first quarter financial results for the three month period ended March 27, 2010. The Company reported net income from continuing operations of $5.5 million, or $0.11 per share, compared to a net loss of $7.0 million, or $0.14 per share, for the period ended March 28, 2009.
Repligen Corporation today announced that the U.S. Food and Drug Administration's Gastrointestinal Drugs Advisory Committee will meet on May 31, 2012 to discuss the Company's New Drug Application (NDA) for SecreFlo for the improved detection of pancreatic duct abnormalities in combination with magnetic resonance imaging (MRI) in patients with pancreatitis.
Merck KGaA, Darmstadt, Germany, today announced the initiation of its multi-national Phase III study of the investigational therapeutic cancer vaccine Stimuvax® (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC).
› Verified 9 days ago
News Archive
Intact Vascular, Inc., a private medical device company committed to developing solutions for minimally invasive peripheral vascular procedures, today announced it received U.S. Food and Drug Administration approval for the Tack Endovascular System, a purpose-built dissection repair device implanted post-angioplasty in patients with peripheral arterial disease.
A study published in the Journal of Biological Chemistry is the first to describe a signaling pathway that affects communication - a process called quorum sensing - between Streptococcus bacteria cells.
Nabi Biopharmaceuticals today announced its first quarter financial results for the three month period ended March 27, 2010. The Company reported net income from continuing operations of $5.5 million, or $0.11 per share, compared to a net loss of $7.0 million, or $0.14 per share, for the period ended March 28, 2009.
Repligen Corporation today announced that the U.S. Food and Drug Administration's Gastrointestinal Drugs Advisory Committee will meet on May 31, 2012 to discuss the Company's New Drug Application (NDA) for SecreFlo for the improved detection of pancreatic duct abnormalities in combination with magnetic resonance imaging (MRI) in patients with pancreatitis.
Merck KGaA, Darmstadt, Germany, today announced the initiation of its multi-national Phase III study of the investigational therapeutic cancer vaccine Stimuvax® (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC).
› Verified 9 days ago
Geisinger Medical Center Acute Care Hospital Location: 100 North Academy Avenue, Danville, Pennsylvania 17822 Phone: (570) 271-6211 | |
Danville State Hospital Psychiatric Hospital Location: 50 Kirkbride Drive, Danville, Pennsylvania 17821 Phone: (570) 271-4500 |